Great Point Partners LLC Ambrx Biopharma Inc. Transaction History
Great Point Partners LLC
- $377 Million
- Q2 2024
A detailed history of Great Point Partners LLC transactions in Ambrx Biopharma Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 97,700 shares of AMAM stock, worth $2.74 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
97,700Holding current value
$2.74 Million% of portfolio
0.22%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMAM
# of Institutions
2Shares Held
31.2KCall Options Held
0Put Options Held
0About Ambrx Biopharma Inc.
- Ticker AMAM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,618,400
- Market Cap $1.08B
- Description
- Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...